EN DE
STOCK COMPARISON

Apotea AB (publ) vs Jd Health International Inc: Fair Value & Quality

Both stocks run through our valuation models. Here is how Apotea AB (publ) (APOTEA) and Jd Health International Inc (6618) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Apotea AB (publ) trades at SEK 73.80 versus a fair value of SEK 43.95 (-40%), while Jd Health International Inc trades at HK$38.94 versus HK$33.28 (-15%).
Apotea AB (publ)
APOTEA.ST · SEK · Health Care
-40%
upside to fair value
overvalued
PriceSEK 73.80
Fair ValueSEK 43.95
Quality52/100
Jd Health International Inc
6618.HK · HKD · Health Care
-15%
upside to fair value
overvalued
PriceHK$38.94
Fair ValueHK$33.28
Quality72/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Apotea AB (publ)Jd Health International Inc
Valuation
32.9×P/E (TTM)17.6×
1.05×P/S (TTM)1.48×
9.22×P/B1.81×
18.8×EV/EBITDA19.4×
—PEG1.26×
0.8%Dividend yield—
SEK 0.60Dividend per share—
Profitability
3%Net margin7%
5%Operating margin4%
28%Return on equity9%
9%Return on assets3%
Growth
11%Revenue growth (YoY)28%
13.8%Avg. growth/yr (3Y)16.3%
—Avg. growth/yr (5Y)30.5%
Balance & size
$822MMarket cap$14B
mixedGrowth qualityhealthy

Even match: 5 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Apotea AB (publ)of which business quality 54 · market factors 33 Jd Health International Incof which business quality 74 · market factors 21
ProfitabilityMargins and returns on capital today
77
47
Quality GrowthAre margins and returns improving?
30
80
CashflowEarnings quality: real cash, not paper profit
29
76
Fin. StrengthBalance sheet, leverage, solvency risk
72
100
InvestmentDisciplined investing over empire-building
32
66
Low VolatilityCalm price path (market factor)
42
42
MomentumPrice trend over the last 3–12 months (market factor)
38
12
52W MomentumDistance to the 52-week high (market factor)
15
14
Net IssuanceBuybacks instead of dilution
74
73

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Apotea AB (publ)

DCF ModelsSEK 63.71
Earnings-BasedSEK 76.91
MultiplesSEK 43.16
Asset-BasedSEK 5.43
Growth DCFSEK 43.84
Economic ProfitSEK 31.99
Growth EarningsSEK 102

17 of 24 models see the stock below the current price.

Jd Health International Inc

DCF ModelsHK$70.32
Earnings-BasedHK$51.28
MultiplesHK$28.65
Asset-BasedHK$12.62
Growth DCFHK$77.68
Economic ProfitHK$20.89
Growth EarningsHK$70.00

10 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Apotea AB (publ)
Bear SEK 26.49Fair Value SEK 43.95Bull SEK 125
SEK 73.80 = current price (white tick)
Jd Health International Inc
Bear HK$25.37Fair Value HK$33.28Bull HK$41.60
HK$38.94 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Apotea AB (publ) · Health Care

Quality score52 · below median
Fair value upside-40% · below median

Jd Health International Inc · Health Care

Quality score72 · Top 25%
Fair value upside-15% · above median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Jd Health International Inc as the less overvalued of the two: Apotea AB (publ) trades at SEK 73.80 versus a fair value of SEK 43.95 (-40%), while Jd Health International Inc trades at HK$38.94 versus HK$33.28 (-15%).

Jd Health International Inc has the higher quality score (72/100).

See the full analysis →
Apotea AB (publ) · Jd Health International Inc

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Apotea AB (publ)

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Jd Health International Inc

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.